This is not the most recent version of the article. View current version (2 OCT 2013)
Anti-vascular endothelial growth factor for neovascular glaucoma
Editorial Group: Cochrane Eyes and Vision Group
Published Online: 8 JUL 2009
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Simha A, Braganza A, Abraham L, Samuel P, Lindsley K. Anti-vascular endothelial growth factor for neovascular glaucoma (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD007920. DOI: 10.1002/14651858.CD007920.
- Publication Status: New
- Published Online: 8 JUL 2009
This is not the most recent version of the article. View current version (02 OCT 2013)
This is the protocol for a review and there is no abstract. The objectives are as follows:
To compare the effects of intraocular anti-VEGF agents to no anti-VEGF injection as an adjunct to existing modalities for the treatment of NVG. In the subgroup of patients with NVG due to CRVO, we will also compare the effects of intraocular anti-VEGF alone to no anti-VEGF injection.